LifeSci Venture Partners

The LifeSci team played an integral role in the formation and successful launch of Engage Therapeutics At all times, I considered them part of my team From the beginning, LifeSci guided me through the investor story, outreach process and strategy for closing

August 2020, Series D-1 Science 37 is a decentralized CRO making the promise of v

March 2019, Series A April 2020, Series B Erasca is a San Diego based biotech company creating a new generation of onc

May 2019, Series C Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disea

January 2019, Series B Beta Bionics is a medical device company developing the breakthrough iLet system which combines

December 2018, Series B Akero is a biotechnology company focused on serious metabolic diseases with a lead program, AK

June 2018, Series B Attune is a clinical-stage biotechnology company focused on novel small-molecule therapeutics for

June 2018, Series C Metacrine is a San Diego based biotechnology company with exceptional chemistry capabilities and a

March 2018, Series B Orasis is a clinical-stage pharmaceutical company developing an innovative eye drop for the treat

March 2018, At-the-MarketNasdaq: NVUS Novus is a specialty pharma company focused on disorders of the near, nose

January 2018, Series DNovember 2018, RTO Columbia Care is one of the largest medical cannabis manufacturers and

November 2017, Series BJuly 2018, IPO - Nasdaq: ALLK Allakos is developing AK002, a first-in-class antibody

March 2017, Series BJanuary 2018, NASDAQ: RCKT Rocket Pharma is developing

September 2017, Series A Engage is developing Staccato® Alprazolam, a small, easy-to-use hand-held drug-device com